This inventor holds 1 USPTO granted patent. Top assignee: Csl Limited. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Sigrid Elisabet Sjolander: Innovator in Immunostimulation
Introduction
Sigrid Elisabet Sjolander is a notable inventor based in Harmanger, Sweden. She has made significant contributions to the field of immunology, particularly in the development of immunostimulating complexes. Her work focuses on utilizing gangliosides for therapeutic applications.
Latest Patents
Sigrid holds a patent for "Ganglioside immunostimulating complexes and uses thereof." This patent describes an immunostimulating complex that comprises one or more gangliosides, such as GM2, GD2, GD3, or GT3. These complexes are useful as prophylactic or therapeutic agents in the treatment of tumors, especially melanomas. She has 1 patent to her name.
Career Highlights
Sigrid is currently associated with CSL Limited, a global biotechnology company known for its innovative therapies. Her work at CSL Limited has allowed her to explore the potential of gangliosides in cancer treatment, contributing to advancements in immunotherapy.
Collaborations
Sigrid has collaborated with notable colleagues, including John Cooper Cox and Bengt John Lennart Ronnberg. These partnerships have enhanced her research and development efforts in the field of immunology.
Conclusion
Sigrid Elisabet Sjolander's innovative work in immunostimulating complexes highlights her significant role in advancing cancer treatment. Her contributions continue to impact the field of immunology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile